Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing chlorocresol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |
Product containing chlorocresol and potassium hydroxyquinoline sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |
Chlorocresol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorocresol |
Inferred relationship |
Some |
|
Chlorocresol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |
Chlorocresol and potassium hydroxyquinoline sulfate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |
Product containing precisely cetylpyridinium chloride 200 microgram/1 gram and chlorocresol 1 milligram/1 gram and lidocaine hydrochloride 9 milligram/1 gram conventional release oromucosal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |
Product containing precisely cetylpyridinium chloride 200 microgram/1 gram and chlorocresol 1 milligram/1 gram and lidocaine hydrochloride 9 milligram/1 gram conventional release oromucosal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium and chlorocresol and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |
Cetylpyridinium and chlorocresol and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium and chlorocresol and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |
Cetylpyridinium and chlorocresol and lidocaine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorocresol |
Inferred relationship |
Some |
1 |